Michael Evanisko - Quintiles IMS Insider

Quintiles IMS Holdings Inc -- USA Stock  

USD 103.48  0.9  0.88%

Independent Director

Mr. Michael J. Evanisko serves as Independent Director of Quintiles Transnational Holdings Inc. Mr. Evanisko is currently Chairman of PARx Solutions, Inc., a provider of processing services for physician practices, where he has served as a director and Chairman since June 2012. From September 2010 to December 2012, Mr. Evanisko served on the board of BackChannel Media, Inc. From July 2008 to May 2011, he served as a consultant to Clarion Healthcare Consulting, LLC, a strategic and organizational consulting firm to pharmaceutical, biotechnology and medical device and diagnostics businesses. From June 2002 to February 2008, Mr. Evanisko served as Executive Chairman of Adheris, Inc., a provider of educational and informational services to patients taking prescription medications. From January 2008 to June 2008, he also served as a consultant to MC Communications, LLC. He received his Bachelors degree in Labor Studies from Pennsylvania State University, his Master of Public Administration from Pennsylvania State University, his Master of Arts in Administrative Sciences from Yale University and his Master of Philosophy from Yale University. Mr. Evanisko serves as a member of the Audit Committee.
Age: 66  Director Since 2010      
919-998-2000  www.quintiles.com
Evanisko is currently Chairman of PARx Solutions, Inc., a provider of processing services for physician practices, where he has served as a director and Chairman since June 2012. From September 2010 to December 2012, Mr. Evanisko served on the board of BackChannel Media, Inc., a broadcast technology developer. From June 2002 to February 2008, Mr. Evanisko served as Executive Chairman of Adheris, Inc., a provider of educational and informational services to patients taking prescription medications. He received his Bachelor?s degree in Labor Studies from Pennsylvania State University, his Master of Public Administration from Pennsylvania State University, his Master of Arts in Administrative Sciences from Yale University and his Master of Philosophy from Yale University.

Management Efficiency

The company has return on total asset of 4.03 % which means that for every 100 dollars spent on asset it generated profit of $4.03. This is acceptable considering the industry classification. Similarly, it shows return on equity (ROE) of 1.89 % implying that it made 1.89 on every $100 invested by shareholders.
The company has accumulated 9.77 B in total debt with debt to equity ratio (D/E) of 130.0 implying that the company may be unable to produce cash to meet its debt commitments. Quintiles IMS Holdings Inc has Current Ratio of 1.2 implying that it may have difficulties to pay its interest payments when they become due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Christopher BodineAllergan plc
2013
Phebe NovakovicAbbott Laboratories
2010
Ronald TaylorAllergan plc
2013
William OsbornAbbott Laboratories
2013
Christopher CoughlinAllergan plc
2016
David AltshulerVertex Pharmaceuticals Incorpor
2015
Joel McCombBio Rad Laboratories Inc
2014
Deborah NeffBio Rad Laboratories Inc
2011
David GreenwayVertex Pharmaceuticals Incorpor
2017
Michael HyattEndo International plc
N/A
Sangeeta BhatiaVertex Pharmaceuticals Incorpor
2015
Samuel ScottAbbott Laboratories
2007
Robert AlpernAbbott Laboratories
2008
Louis DrapeauBio Rad Laboratories Inc
2007
Jill SmithEndo International plc
2012
Nancy HutsonEndo International plc
2009
Michael GallagherAllergan plc
2015
James BloemAllergan plc
2013
Terrence KearneyVertex Pharmaceuticals Incorpor
2011
Alice SchwartzBio Rad Laboratories Inc
1967
Daniel StarksAbbott Laboratories
2017

Entity Summary

Quintiles IMS Holdings, Inc. offer biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the AsiaPacific. Quintiles IMS Holdings Inc (Q) is traded on New York Stock Exchange in USA. It is located in 4820 Emperor Blvd., Durham, NC 27703, United States and employs 36,100 people.

Did you try this?

Run Fundamentals Matrix Now
   

Fundamentals Matrix

View fundamentals matrix and analyze how accounts are interrelated and interconnected with each other
Hide  View All  NextLaunch Fundamentals Matrix
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Quintiles IMS Holdings Inc to your portfolio

Top Management

Quintiles IMS Holdings Leadership Team
Ari Bousbib, Director, MBA
Michael Evanisko, Director
Leonard Schaeffer, Director
James Erlinger, President, MBA
John Danhakl, Director, MBA
Michael McDonnell, President
Kevin Gordon, COO
John Leonard, Director, Ph.D
James Fasano, Director, MBA
Jonathan Coslet, Director, MBA
Anand MD, Executive
Christopher Gordon, Director, MBA
John Connaughton, Director, MBA
Haiyuan Lo, Director
Dennis Gillings, Chairman, Ph.D
Todd Sisitsky, Director, MBA
Jack Greenberg, Director, CPA
Thomas Pike, CEO
Fred Cohen, Director
Richard Staub, President
MRCA MBBS, Executive
Mireille Gillings, Director, Ph.D
Richard Relyea, Director
Ronald Rittenmeyer, Director, MBA
Kevin Knightly, President

Stock Performance

Quintiles IMS Performance Indicators